Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
Yatharth Hospital & Trauma Care Services Ltd (YATHARTH)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543950 NSE: YATHARTH Hospital & Healthcare Services | Small Cap | Yatharth Hospital Share Price
₹1,099.75 -20.85 (-1.86%)
As on 28-Sep'26 16:59
Yatharth Hospital & Trauma Care Services Ltd (YATHARTH)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 543950 NSE: YATHARTH Hospital & Healthcare Services | Small Cap | Yatharth Hospital Share Price
₹1,099.75 -20.85 (-1.86%)
As on 28-Sep'26 16:59
Key Metrics
Valuation Multiples
Market Cap
₹10,597 Cr.
Current Price
₹1,099.8
52-Week Low / High
₹538 / 1,183
TTM EPS
₹18.8
TTM Sales
₹1,334 Cr.
Book Value per Share
₹189.5
P/E Ratio
58.49
Higher than its 5-year historical median
Industry PE
98.6
Price to Book (P/B)
5.80
Higher than its 5-year historical median
Price to Sales (P/S)
7.94
Lower than its 5-year historical median
EV/EBITDA
31.22
In line with its 5-year historical median
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
10.06%
Underperforms industry median
Return on Capital Employed (ROCE)
13.30%
Underperforms industry median
Return on Assets (ROA)
8.58%
Operating Profit Margin
25.3%
Net Profit Margin
14.11%
Gross Profit Margin
25.8%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
29.66%
Operating Profit Growth (1 Year)
Improving versus 3-year growth rate
32.13%
Net Profit Growth (1 Year)
Slowing versus 3-year growth rate
30.46%
Asset Quality
Promoter Holding
55.80%
Pledged shares (%) of Promoter's holding (%)
9.59%
Reserves
₹1,730 Cr.
Equity
₹96.4 Cr.
Face Value
₹10
All Time Low / High
₹304.00 / 1183.15
Check Before You Invest
Quality
Somewhat GoodValuation
OvervaluedCheck Valuation charts
Price Trend
Strong
Is Yatharth Hospital & Trauma Care Services Ltd a good quality company?
Yatharth Hospital & Trauma Care Services Ltd is a average quality company, based on a somewhat consistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does Yatharth Hospital & Trauma Care Services Ltd performance compare with that of its Peers?
Revenue growth of Yatharth Hospital & Trauma Care Services Ltd vs industry peers?
Yatharth Hospital & Trauma Care Services Ltd revenue CAGR is 39.48%, compared to the industry median CAGR of 0%, indicating faster growth and gaining its market share.
Promoter shareholding and pledge status of Yatharth Hospital & Trauma Care Services Ltd?
Promoters hold 55.80% of the Yatharth Hospital & Trauma Care Services Ltd, with 9.59% of their stake pledged, indicating low pledge risk.
Stock return of Yatharth Hospital & Trauma Care Services Ltd over the last decade?
Over the last 3 year(s), the stock has delivered a CAGR of 44.39% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Yatharth Hospital & Trauma Care Services Ltd has performed well in some of the past ten years indicating its past ten year financial track record is somewhat good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 0% | 0% | 7.1% | 9.7% | 17.9% | 37.2% | 37.3% | 21.1% | 10.4% | 8.2% | - |
| Value Creation Index ⓘ | NA | NA | -0.5 | -0.3 | 0.3 | 1.8 | 1.7 | 0.5 | -0.3 | -0.4 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 0 | 0 | 102 | 133 | 165 | 299 | 372 | 420 | 456 | 592 | 636 |
| Sales YoY Gr. | - | NA | NA | 30.3% | 24.1% | 81.3% | 24.4% | 13% | 8.7% | 29.7% | - |
| Adj EPS ⓘ | 0 | 0 | 0.4 | 0.1 | 1.9 | 6.4 | 9.8 | 9.8 | 9.1 | 9.9 | 10 |
| YoY Gr. | - | NA | NA | -72.7% | 1466.7% | 241.5% | 52.7% | -0.2% | -7% | 8.8% | - |
| BVPS (₹) ⓘ | 0 | 0 | 8.5 | 8.6 | 10.6 | 17.1 | 26.9 | 97.5 | 158.3 | 168.1 | 171 |
| Adj Net Profit ⓘ | 0 | 0 | 2.9 | 0.8 | 12.3 | 42.1 | 64.2 | 84 | 87.7 | 95.4 | 96 |
| Cash Flow from Ops. ⓘ | 0 | 0 | 19 | 23.5 | 25.8 | 26.8 | 25.6 | 16 | 94.5 | 94.6 | - |
| Debt/CF from Ops. ⓘ | 0 | 0 | 6.3 | 4.8 | 4 | 4.1 | 4.4 | 0.2 | 0 | 2.4 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | NA | 29.2% | 16.8% | 29.7% | ||||
| Adj EPS ⓘ | NA | 39.4% | 0.3% | 8.8% | ||||
| BVPSⓘ | NA | 73.8% | 84.2% | 6.2% | ||||
| Share Price | - | - | 42.8% | 46.6% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 0 | 0 | 5.2 | 1.4 | 19.6 | 46.5 | 44.6 | 16.6 | 7.4 | 6.1 | 5.9 |
| Op. Profit Mgn % ⓘ | 0 | 0 | 19.4 | 23.7 | 27 | 28.5 | 28.6 | 28.3 | 29 | 24.6 | 22.5 |
| Net Profit Mgn % ⓘ | 0 | 0 | 2.9 | 0.6 | 7.5 | 14.1 | 17.3 | 20 | 19.2 | 16.1 | 15.2 |
| Debt to Equity ⓘ | 0 | 0 | 2.2 | 2 | 1.5 | 1 | 0.7 | 0 | 0 | 0.1 | - |
| Working Cap Days ⓘ | 0 | 0 | 0 | 75 | 86 | 97 | 128 | 260 | 494 | 506 | 137 |
| Cash Conv. Cycle ⓘ | 0 | 0 | 0 | 9 | 25 | 42 | 61 | 88 | 117 | 97 | 116 |
Valuation of Yatharth Hospital - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 13.81 | 13.81 | 15.33 | 10.73 | 10.73 | 9.59 |
* Pledged shares as % of Promoter's holding (%)
Financials
| PARTICULARS | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|
| Sales | 102 | 146 | 229 | 401 | 520 | 671 | 886 | 1,207 |
| Operating Expenses ⓘ + | 82 | 108 | 161 | 289 | 385 | 489 | 655 | 903 |
| Operating Profit ⓘ | 20 | 38 | 68 | 112 | 135 | 182 | 230 | 304 |
| Operating Profit Margin (%) | 19.7% | 26.3% | 29.8% | 27.9% | 26.0% | 27.1% | 26.0% | 25.2% |
| Other Income ⓘ + | 0 | 0 | 1 | 2 | 3 | 16 | 11 | 26 |
| Interest ⓘ | 7 | 20 | 20 | 23 | 23 | 11 | 13 | 19 |
| Depreciation ⓘ | 8 | 21 | 21 | 28 | 28 | 29 | 57 | 88 |
| Profit Before Tax ⓘ | 5 | -2 | 28 | 63 | 88 | 157 | 172 | 224 |
| Tax ⓘ | 1 | -0 | 9 | 19 | 22 | 42 | 41 | 53 |
| Profit After Tax | 4 | -2 | 20 | 44 | 66 | 114 | 131 | 170 |
| PAT Margin (%) | 3.9% | -1.4% | 8.6% | 11.0% | 12.6% | 17.1% | 14.7% | 14.1% |
| Adjusted EPS (₹) | 0.6 | -0.2 | 2.8 | 6.7 | 10.0 | 13.3 | 13.6 | 18.2 |
| Dividend Payout Ratio (%) | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| PARTICULARS | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | |||
|---|---|---|---|---|---|---|---|---|---|---|---|
Equity and Liabilities | |||||||||||
| Shareholders Fund + | 56 | 54 | 72 | 117 | 183 | 874 | 1,605 | 1,781 | |||
| Debt + | 153 | 163 | 168 | 223 | 217 | 75 | 4 | 227 | |||
| Minority Interest | 3 | 8 | 8 | 0 | 0 | 0 | 32 | 27 | |||
| Trade Payables | 13 | 14 | 17 | 20 | 17 | 29 | 29 | 110 | |||
| Others Liabilities ⓘ | 33 | 48 | 44 | 61 | 61 | 30 | 43 | 111 | |||
| Total Liabilities ⓘ | 257 | 287 | 309 | 421 | 478 | 1,009 | 1,713 | 2,255 | |||
Fixed Assets | |||||||||||
| Net Fixed Assets ⓘ + | 164 | 189 | 251 | 303 | 299 | 442 | 605 | 1,250 | |||
| CWIP ⓘ | 65 | 62 | 0 | 0 | 0 | 0 | 222 | 102 | |||
| Investments ⓘ | 0 | 0 | 0 | 0 | 0 | 0 | 74 | 2 | |||
| Inventories | 2 | 3 | 3 | 5 | 6 | 8 | 21 | 21 | |||
| Trade Receivables | 12 | 17 | 37 | 86 | 108 | 227 | 302 | 375 | |||
| Cash Equivalents | 0 | 2 | 5 | 12 | 38 | 239 | 441 | 263 | |||
| Others Assets ⓘ | 13 | 15 | 13 | 15 | 27 | 93 | 48 | 242 | |||
| Total Assets ⓘ | 257 | 287 | 309 | 421 | 478 | 1,009 | 1,713 | 2,255 | |||
| PARTICULARS | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 |
|---|---|---|---|---|---|---|---|---|
| Cash Flow From Operating Activity ⓘ + | 17 | 39 | 44 | 60 | 64 | -3 | 131 | 205 |
| Cash Flow From Investing Activity ⓘ + | -78 | -43 | -21 | -52 | -20 | -226 | -388 | -598 |
| Cash Flow From Financing Activity ⓘ + | 47 | 5 | -19 | -1 | -18 | 304 | 509 | 254 |
| Net Cash Flow ⓘ | -13 | 1 | 3 | 7 | 26 | 75 | 253 | -140 |
| PARTICULARS | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Ratios | ||||||||||
| ROE (%) | 7.15 | -3.74 | 30.91 | 46.65 | 43.87 | 21.65 | 10.53 | 10.06 | ||
| ROCE (%) | 5.4 | 7.53 | 19.3 | 27.07 | 26.88 | 23.97 | 14.35 | 13.3 | ||
| Asset Turnover Ratio | 0.4 | 0.54 | 0.77 | 1.1 | 1.16 | 0.9 | 0.65 | 0.61 | ||
| PAT to CFO Conversion(x) | 4.25 | N/A | 2.2 | 1.36 | 0.97 | -0.03 | 1 | 1.21 | ||
| Working Capital Days | ||||||||||
| Receivable Days | 42.80 | 36 | 42.80 | 55.70 | 67.80 | 91.10 | 108.90 | 102.20 | ||
| Inventory Days | 8.10 | 6.40 | 5 | 3.90 | 4 | 3.90 | 6 | 6.30 | ||
| Payable Days | 489.50 | 332 | 165.20 | 134.80 | 153.40 | 138.40 | 60.30 | 108.20 | ||
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
Yatharth Hospital & Trauma Care Services Ltd FAQs
The current trading price of Yatharth Hospital on 28-Sep-2026 16:59 is ₹1,099.8.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 27-Sep-2026 the market cap of Yatharth Hospital stood at ₹10,596.6 Cr
The latest P/E ratio of Yatharth Hospital as of 27-Sep-2026 is 109.9.
The latest P/B ratio of Yatharth Hospital as of 27-Sep-2026 is 6.43.
The 52-week high of Yatharth Hospital is ₹1,183.2 and the 52-week low is ₹538.1.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Yatharth Hospital is ₹636 ( Cr.) .
Past 10 year's financial track record analysis by Moneyworks4me indicates that Yatharth Hospital & Trauma Care Services Ltd is a average quality company.
The key valuation ratios of Yatharth Hospital & Trauma Care Services Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Strong which suggest that the price of Yatharth Hospital & Trauma Care Services Ltd is likely to Rise in the short term. However, please check the rating on Quality and Valuation before investing
About Yatharth Hospital & Trauma Care Services Ltd
Yatharth Hospital & Trauma Care Services is a network of super speciality hospitals across Delhi National Capital Region (NCR) and Madhya Pradesh, capitalising on the robust healthcare infrastructure in these regions to serve a wide patient base in need of tertiary care. The company’s hospitals have been designed to comply with international quality standards with its Noida Extension Hospital accredited by Joint Commission International (JCI), USA and all its hospitals accredited by the National Accreditation Board for Hospitals (NABH). The company’s hospitals have been built on a foundation of talent, trust, technology, service and infrastructure.
All of its hospitals offer spacious suites along with modern deluxe and super deluxe rooms, and comfortable patient waiting areas. The company’s diagnostic areas are designed with the goals of providing patient-friendly, spacious and relaxing environments. The company has advanced medical equipment such as Azurion catheterization laboratory and are equipped with the latest robotics surgical equipments like the DaVinci, Mako and Cuvis, 1.5 Tesla whole-body MRI with optical digital broadband and embedded express coil technology for minimal patient repositioning and advanced non-contrast MR Angiography, 128 slice CT scan, endo bronchial ultrasound, nerve conduction velocity (NCV), advanced surgical equipment including Thulium Uro laser, flexible scope, advance laparoscope, advance microscopes, Cusa set. These advanced equipments provide for a better and more accurate diagnosis, as well as insight into the surgical procedure, which increases the surgical success rate.
Some of its modular operation theatres are equipped with high efficiency particulate air (HEPA) filters and laminar flow, operating microscopes with image intensifiers. The company’s in-house diagnostic radiology setup and diagnostic labs are well-equipped centres with comprehensive diagnostic capabilities including, haematology, biochemistry, microbiology, molecular biology and histopathology along with 24x7 in-house pharmacy shops.
Business area of the company
The company is engaged in the business of providing healthcare services, operating hospitals and other allied services, as may be required for the provision of healthcare services. The company has one hospital each in Noida and Greater Noida.
Awards and Accreditations
- 2020: Recognized as Emerging Hospital Chain in Delhi NCR by Medico Trip India.
- 2020: Awarded 1stPrize in Swachhta Ranking Competition in the category of Swachh Hospital (for the quarter ended June 2019) in compliance with Swachh Survekshan League 2020 by Noida Authority.
- 2020: Awarded 1st Rank in Swachhta Ranking Competition in the category of Swachh Hospital (for the quarter ended September 2019) in compliance with Swachh Survekshan League 2020 by Noida Authority.
- 2021: Certificate of appreciation as ‘Heroes’-Beyond the Call of Duty from Tata Consultancy Services.
- 2021: Covid Thank You Award by Niva Bupa.
- 2021: 5 star grading by Infomerics Analysts & Research Private Limited for its hospitals located at Noida, Noida Extension and Greater Noida.
- 2023: Awarded UP Ratan Samman by Dainik Jagran Inext.
- 2024-25: Awarded the Best Brand for Excellence in Healthcare at the Economic Times (ET) Edge Best Brands Conclave, in recognition to its consistent innovation and customer-centric approach
- 2024-25: Noida Extension Hospital accredited by Joint Commission International (JCI) – the first hospital in Uttar Pradesh and seventh in North India to receive this prestigious global accreditation
Milestones
- 2008: Incorporated the Company and commenced operations
- 2010: Established first hospital in Greater Noida
- 2013: Established its second hospital, a 250-bed hospital facility in Noida
- 2018: Expanded its first hospital, Greater Noida hospital to 400 beds
- 2019: Commenced operations of its third hospital in, Noida Extension, in May 2019, following the acquisition of its subsidiary AKS in 2016
- 2022: Acquired its fourth hospital, the Jhansi Orchha hospital, adding 305 beds, through the acquisition of Ramraja Multispeciality Hospital
- 2023: Listed on the National Stock Exchange (NSE) and Bombay Stock Exchange (BSE)
- 2024: Acquired its fifth hospital, in Faridabad, Delhi NCR, adding 200 beds
- 2025: Successfully acquired two hospital, first in Model Town , Delhi and second in Sector 20, Faridabad, Haryana
You have 49 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
